Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
New York Genome Center | RCV001281559 | SCV001468869 | uncertain significance | not provided | 2019-07-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002375324 | SCV002690766 | uncertain significance | Inborn genetic diseases | 2018-02-27 | criteria provided, single submitter | clinical testing | The p.V427I variant (also known as c.1279G>A), located in coding exon 6 of the MID1 gene, results from a G to A substitution at nucleotide position 1279. The valine at codon 427 is replaced by isoleucine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV001281559 | SCV004371749 | benign | not provided | 2023-08-29 | criteria provided, single submitter | clinical testing |